Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Study of SU5416, an Antiangiogenesis Agent, in Combination With Carboplatin in Patients With Platinum-Refractory Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2008-03-04A Clinical Trial of the P-Glycoprotein Antagonist, XR9576, in Combination With Vinorelbine in Patients With Cancer: Analysis of the Interaction Between XR9576 and Vinorelbine
-
CLINICAL_TRIALS study record update · 2008-01-03A Phase II Trial of ModifiedTriple Doublet Therapy in the Treatment of Women With Newly Diagnosed Carcinoma of Müllerian Origin
-
CLINICAL_TRIALS study record update · 2007-12-18A Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of Intravenous OvaRex® MAb-B43.13 as Post Chemotherapy Consolidation for Epithelial Carcinoma of Ovarian, Tubal or Peritoneal Origin
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2007-12-18An Open-Label, Phase II Study of Ovarex® MAb-B43.13 as an Adjuvant Treatment to Platinum-Based Front-Line Chemotherapy of Advanced Epithelial Carcinoma of Ovarian, Tubal, or Peritoneal Origin
-
CLINICAL_TRIALS study record update · 2007-09-21Randomized, Double-Blind, Phase III Trial of Chemotherapy Plus the Transcriptional Therapy Hydralazine and Magnesium Valproate Versus Chemotherapy Plus Placebo in Cisplatin-Resistant Recurrent Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2007-09-11Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer: Pilot Trial of a Phase I/II Study
-
CLINICAL_TRIALS study record update · 2007-08-17A Phase II Study Designed to Evaluate the Safety and Efficacy of the Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Early Relapse Patients (< 6 Months) With Ovarian Cancer, Overexpressing HER2, Previously Treated With Carboplatin-Paclitaxel
-
CLINICAL_TRIALS study record update · 2007-08-13The Development of Human Immunologic Assays Specific to Folate Receptor Antigen
-
CLINICAL_TRIALS study record update · 2007-05-25Continuation of Treatment and Monitoring of Safety in Patients Treated With LY353381 for Advanced Cancer
-
CLINICAL_TRIALS study record update · 2007-04-20Værdien af MRI Til Staging af c.Ovarii-et Prospektivt Studie
-
CLINICAL_TRIALS study record update · 2007-03-02Study to Assess the Effectiveness of the CAAb Test With Ovarian Cancer Patients
-
CLINICAL_TRIALS study record update · 2007-02-12A Pilot Study of the Herbal Remedy Essiac (ESIAK ®) Versus Placebo in Improving the Quality of Life in Women Completing Adjuvant Treatment for Breast or Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers.
-
CLINICAL_TRIALS study record update · 2007-01-08Proteomic Analysis of Serology and Peptides Presented on the HLA Complex of Breast, Ovarian, Colon, Rectal, Gastric and Pancreatic Adenocarcinoma.
-
CLINICAL_TRIALS study record update · 2006-12-19ClinicalTrials.gov study NCT00173394
-
CLINICAL_TRIALS study record update · 2006-11-14A Randomized Phase III Study Comparing Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Epithelial Ovarian Carcinoma Who Failed First-Line Platinum-Based Therapy
-
CLINICAL_TRIALS study record update · 2006-11-08Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients
-
CLINICAL_TRIALS study record update · 2006-10-02A Phase I/II Trial of ACA 125 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2006-09-15ClinicalTrials.gov study NCT00055432
-
CLINICAL_TRIALS study record update · 2006-09-13A Phase II Trial of Weekly Topotecan As Consolidation Therapy in Ovarian Cancer Patients After Initial Chemotherapy
-
CLINICAL_TRIALS study record update · 2006-08-18Effects of Acupuncture on Pain, Nausea, Quality of Life
-
CLINICAL_TRIALS study record update · 2006-08-04Phase III Multicenter Study in Epithelial Ovarian Carcinoma FIGO Stage IIB-IV Comparing Treatment With Paclitaxel and Carboplatin to Paclitaxel and Carboplatin Sequentially Followed by Topotecan